SOAM
MIRM icon

SBI Okasan Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History

SBI Okasan Asset Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.75M Hold
14,200
– – 0.06% 62
2026
Q1 		$1.25M Sell
14,200
-1,800
-11% -$169K 0.05% 82
2025
Q4 		$1.28M Buy
+16,000
New +$1.15M 0.07% 94

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SBI Okasan Asset Management's MIRM Position: Q2 2026 in Review

SBI Okasan Asset Management held its Mirum Pharmaceuticals (MIRM) position steady in Q2 2026 at 14,200 shares worth $1.75M. The position accounts for 0.06% of the portfolio, ranked #62.

SBI Okasan Asset Management first reported a position in MIRM in Q4 2025 and has held it in 3 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • SBI Okasan Asset Management held 14,200 shares of Mirum Pharmaceuticals worth $1.75M as of Q2 2026.
  • SBI Okasan Asset Management left its Mirum Pharmaceuticals share count unchanged in Q2 2026.
  • Mirum Pharmaceuticals made up 0.06% of SBI Okasan Asset Management's portfolio in Q2 2026, its #62 holding.
  • SBI Okasan Asset Management first reported a position in Mirum Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on SBI Okasan Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.